In Vivo Dopamine Neuron Imaging-Based Small Molecule Screen Identifies Novel Neuroprotective Compounds and Targets

Parkinson’s disease (PD) is the second most common neurodegenerative disorder with prominent dopamine (DA) neuron degeneration. PD affects millions of people worldwide, but currently available therapies are limited to temporary relief of symptoms. As an effort to discover disease-modifying therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Gha-hyun J., Mo, Han, Liu, Harrison, Okorie, Meri, Chen, Steven, Zheng, Jiashun, Li, Hao, Arkin, Michelle, Huang, Bo, Guo, Su
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971663/
https://www.ncbi.nlm.nih.gov/pubmed/35370735
http://dx.doi.org/10.3389/fphar.2022.837756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971663/
https://www.ncbi.nlm.nih.gov/pubmed/35370735
http://dx.doi.org/10.3389/fphar.2022.837756

Ejemplares similares